Prognostic factors in the treatment of human immunodeficiency virus- associated non-Hodgkin's lymphoma: Analysis of AIDS clinical trials group protocol 142 - Low-dose versus standard-dose m-BACOD plus granulocyte- macrophage colony-stimulating factor Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Lymphoma, AIDS-Related

abstract

  • Long-term survival can be achieved in approximately one third of patients with HIV-associated NHL with favorable characteristics.

publication date

  • November 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9817281

Additional Document Info

start page

  • 3601

end page

  • 6

volume

  • 16

number

  • 11